Libo Sun
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 10
- Psoriasis: Treatment and Pathogenesis 5
- T-cell and B-cell Immunology 3
- interferon and immune responses 1
- Immunotherapy and Immune Responses 1
- Genetics 1
- Mesenchymal stem cell research 1
- Co-authors
- Fangzhou Lou (9 shared papers)Zhikai Wang (9 shared papers)Hong Wang (7 shared papers)Hong Zhou (7 shared papers)Qianqian Yin (7 shared papers)Xiaojie Cai (8 shared papers)Jing Bai (5 shared papers)Liman Niu (3 shared papers)
In The Last Decade
Libo Sun
14 papers receiving 490 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 105
- Immunology 144
- Drug Discovery 1
- Dermatology 28
- Molecular Biology 121
Countries citing papers authored by Libo Sun
This map shows the geographic impact of Libo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Sun more than expected).
Fields of papers citing papers by Libo Sun
This network shows the impact of papers produced by Libo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Sun. The network helps show where Libo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 159 | |
| 2 | 2020 | 119 | |
| 3 | 2023 | 42 | |
| 4 | 2020 | 32 | |
| 5 | 2022 | 27 | |
| 6 | 2019 | 24 | |
| 7 | 2022 | 23 | |
| 8 | 2000 | 20 | |
| 9 | 2004 | 16 | |
| 10 | 2024 | 16 | |
| 11 | 2021 | 7 | |
| 12 | 2025 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 1 |
About Libo Sun
Libo Sun is a scholar working on Immunology, Genetics, Cancer Research, Pharmacology and Oncology, having authored 14 papers that have together received 498 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (5 papers), T-cell and B-cell Immunology (3 papers), interferon and immune responses (1 paper), RNA and protein synthesis mechanisms (1 paper), Mesenchymal stem cell research (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Cancer Research (105 citations), Immunology (144 citations), Drug Discovery (1 citation), Dermatology (28 citations) and Molecular Biology (121 citations). Libo Sun has collaborated with scholars based in China, Japan and Singapore. Frequent co-authors include Fangzhou Lou, Zhikai Wang, Hong Wang, Hong Zhou, Qianqian Yin, Xiaojie Cai, Jing Bai, Liman Niu, Linjiao Chen and Yang Sun. Their work appears in journals such as Nature Communications, EMBO Reports, The Journal of Immunology, Hypertension and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.